Skip to main content

PerkinElmer Eliminated 229 Positions in Q2

NEW YORK (GenomeWeb News) – PerkinElmer reduced its headcount by 229 employees in the second quarter, the company disclosed in a document filed with the US Securities and Exchange Commission on Tuesday.

In its Form 10-Q, the firm said that the workforce reduction was made as part of a plan approved during the second quarter by management to realign operations, R&D resources, and production resources as a result of recent acquisitions. The firm has been quiet on the M&A front this year in the 'omics-related life science tools space, but during 2011 PerkinElmer made seven acquisitions, including its $600 million buy of Caliper Life Sciences.

As a result of the restructuring plan, PerkinElmer recognized a $4.0 million pretax restructuring charge in the Human Health segment, as well as a $200,000 pretax restructuring charge in the Environment Health segment, related to the headcount reduction from reorganization efforts.

It added that it expects to recognize an additional $5.4 million of incremental restructuring expense in "future periods."

The layoffs come on top of 243 positions that were eliminated by PerkinElmer during the first quarter of 2012 and fourth quarter of 2011 due to restructuring.

Other firms in the 'omics tools space have also recently implemented workforce reductions as they restructure their businesses. Thermo Fisher Scientific disclosed last week it eliminated 530 jobs in the first half of the year, and Roche is reducing its workforce by 120 positions as a result of the shutdown of its NimbleGen microarray business, as GenomeWeb Daily News' sister publication BioArray News recently reported.

Meanwhile, Complete Genomics and WaferGen also announced layoffs this year.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.